research-article

View from Public Health to Molecular Biology on Coronavirus Disease 2019 (COVID-19)

Author:

Yuru LiAuthors Info & Claims

ICBBE '20: Proceedings of the 2020 7th International Conference on Biomedical and Bioinformatics Engineering

Pages 194 - 197

https://doi.org/10.1145/3444884.3444922

Published: 31 March 2021 Publication History

Abstract

The outbreak of the new coronavirus disease (COVID-19) shocked the world and the epidemic was still undergoing. 213 countries were affected and around 10 million people were infected. What's worse, so far, no effective drug has been found to cure patients. SARS-CoV-2 was the name of the virus and all the things we knew about it was not so much. In this article, we shared a comprehensive view on the COVID-19, from the view of public health and molecular biology.

References

[1]

Wang, C.; Horby, P. W.; Hayden, F. G.; Gao, G. F., A novel coronavirus outbreak of global health concern. Lancet 2020, 395 (10223), 470-473.

[2]

Chen, F.; Liu, Z. S.; Zhang, F. R.; Xiong, R. H.; Chen, Y.; Cheng, X. F.; Wang, W. Y.; Ren, J., [First case of severe childhood novel coronavirus pneumonia in China]. Zhonghua Er Ke Za Zhi 2020, 58 (3), 179-182.

[3]

Zeng, L. K.; Tao, X. W.; Yuan, W. H.; Wang, J.; Liu, X.; Liu, Z. S., [First case of neonate infected with novel coronavirus pneumonia in China]. Zhonghua Er Ke Za Zhi 2020, 58 (0), E009.

[4]

Huang, P.; Liu, T.; Huang, L.; Liu, H.; Lei, M.; Xu, W.; Hu, X.; Chen, J.; Liu, B., Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical Suspicion. Radiology 2020, 295 (1), 22-23.

[5]

Piva, S.; Filippini, M.; Turla, F.; Cattaneo, S.; Margola, A.; De Fulviis, S.; Nardiello, I.; Beretta, A.; Ferrari, L.; Trotta, R.; Erbici, G.; Foca, E.; Castelli, F.; Rasulo, F.; Lanspa, M. J.; Latronico, N., Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J Crit Care 2020, 58, 29-33.

[6]

de Koning, H. J.; van der Aalst, C. M.; de Jong, P. A.; Scholten, E. T.; Nackaerts, K.; Heuvelmans, M. A.; Lammers, J. J.; Weenink, C.; Yousaf-Khan, U.; Horeweg, N.; van 't Westeinde, S.; Prokop, M.; Mali, W. P.; Mohamed Hoesein, F. A. A.; van Ooijen, P. M. A.; Aerts, J.; den Bakker, M. A.; Thunnissen, E.; Verschakelen, J.; Vliegenthart, R.; Walter, J. E.; Ten Haaf, K.; Groen, H. J. M.; Oudkerk, M., Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med 2020, 382 (6), 503-513.

[7]

Kumar, P.; Abdelrahman, K.; Das, B.; Tp, S.; Dey, A. K., Williams-Beuren Syndrome: The Role of Cardiac CT in Diagnosis. Methodist Debakey Cardiovasc J 2020, 16 (1), 61-64.

[8]

Wang, D.; Hu, B.; Hu, C.; Zhu, F.; Liu, X.; Zhang, J.; Wang, B.; Xiang, H.; Cheng, Z.; Xiong, Y.; Zhao, Y.; Li, Y.; Wang, X.; Peng, Z., Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020.

[9]

Look, A. R. G.; Lewis, C. E.; Bantle, J. P.; Bertoni, A. G.; Blackburn, G.; Brancati, F. L.; Bray, G. A.; Cheskin, L. J.; Curtis, J. M.; Egan, C.; Evans, M.; Foreyt, J. P.; Ghazarian, S.; Barone Gibbs, B.; Glasser, S. P.; E, W. G.; Hazuda, H. P.; Hesson, L.; Hill, J. O.; Horton, E. S.; Hubbard, V. S.; Jakicic, J. M.; Jeffery, R. W.; Johnson, K. C.; Kahn, S. E.; Kitabchi, A. E.; Kitzman, D.; Knowler, W. C.; Lipkin, E.; Michaels, S.; Montez, M. G.; Nathan, D. M.; Nyenwe, E.; Patricio, J.; Peters, A.; Pi-Sunyer, X.; Pownall, H.; Reboussin, D. M.; Ryan, D. H.; Wadden, T. A.; Wagenknecht, L. E.; Wyatt, H.; Wing, R. R.; Yanovski, S. Z., History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial. Obesity (Silver Spring) 2020, 28 (2), 247-258.

[10]

Wrapp, D.; Wang, N.; Corbett, K. S.; Goldsmith, J. A.; Hsieh, C. L.; Abiona, O.; Graham, B. S.; McLellan, J. S., Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. bioRxiv 2020.

[11]

Dai, W.; Zhang, B.; Jiang, X. M.; Su, H.; Li, J.; Zhao, Y.; Xie, X.; Jin, Z.; Peng, J.; Liu, F.; Li, C.; Li, Y.; Bai, F.; Wang, H.; Cheng, X.; Cen, X.; Hu, S.; Yang, X.; Wang, J.; Liu, X.; Xiao, G.; Jiang, H.; Rao, Z.; Zhang, L. K.; Xu, Y.; Yang, H.; Liu, H., Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 2020, 368 (6497), 1331-1335.

[12]

Chi, X.; Yan, R.; Zhang, J.; Zhang, G.; Zhang, Y.; Hao, M.; Zhang, Z.; Fan, P.; Dong, Y.; Yang, Y.; Chen, Z.; Guo, Y.; Zhang, J.; Li, Y.; Song, X.; Chen, Y.; Xia, L.; Fu, L.; Hou, L.; Xu, J.; Yu, C.; Li, J.; Zhou, Q.; Chen, W., A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science 2020.

[13]

Watanabe, Y.; Allen, J. D.; Wrapp, D.; McLellan, J. S.; Crispin, M., Site-specific glycan analysis of the SARS-CoV-2 spike. Science 2020.

[14]

Zhang, L.; Lin, D.; Sun, X.; Curth, U.; Drosten, C.; Sauerhering, L.; Becker, S.; Rox, K.; Hilgenfeld, R., Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science 2020, 368 (6489), 409-412.

[15]

Zhang, L.; Liu, Y., Potential interventions for novel coronavirus in China: A systematic review. J Med Virol 2020, 92 (5), 479-490.

Cited By

Moroh JInnocent DChukwuocha UVasavada AKumar RSiddiq MRais MRabaan AAlshehri WAlharbi ABinateeq MHalwani MAl-Ahdal TPadhi BSah R(2023)Seasonal Variation and Geographical Distribution of COVID-19 across Nigeria (March 2020–July 2021)Vaccines10.3390/vaccines1102029811:2(298)Online publication date: 29-Jan-2023
https://doi.org/10.3390/vaccines11020298
Sharma SRani RKalra N(2023)Genomic Characterization of Emerging SARS-CoV-2: A Systematic ReviewCurrent Bioinformatics10.2174/157489361866623022811542318:5(375-408)Online publication date: Jun-2023
https://doi.org/10.2174/1574893618666230228115423

Recommendations

A Molecular View of Coronavirus Disease-2019 (COVID-19)
ICBBE '20: Proceedings of the 2020 7th International Conference on Biomedical and Bioinformatics Engineering

This article reviews the research progress of the spike protein of the virus SARS-CoV-2 that causes COVID-19, including the gene sequence and protein sequence encoding the spike protein, as well as its secondary and tertiary structure through ...
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
Abstract
SARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although several FDA-approved drugs are currently under clinical trials for drug repositioning, there is an on-going global effort for new drug ...
Graphical abstract

Display Omitted
Highlights
- SARS-CoV-2 shares Influenza, EBV, HTLV-I, Measles, and Hepatitis virus infection pathways.
- SARS-CoV-2 also shares Tuberculosis, Malaria, and Leishmaniasis infection pathways.
- mRNA splicing, cytokine and IFN signaling, and ubiquitin ...
Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants – Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) – A molecular docking and simulation study
Abstract
Coronavirus Disease-2019 (COVID-19), a viral disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was declared a global pandemic by WHO in 2020. In this scenario, SARS-CoV-2 main protease (COVID-19 M^pro), an ...
Highlights
- 96 bioactive compounds were screened computationally to search potential inhibitors for COVID-19 Main protease.

Comments

Information & Contributors

Information

Published In

cover image ACM Other conferences

ICBBE '20: Proceedings of the 2020 7th International Conference on Biomedical and Bioinformatics Engineering

November 2020

197 pages

ISBN:9781450388221

DOI:10.1145/3444884

Copyright © 2020 ACM.

Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

Publisher

Association for Computing Machinery

New York, NY, United States

Publication History

Published: 31 March 2021

Permissions

Request permissions for this article.

Request Permissions

Check for updates

Author Tags

Qualifiers

Research-article
Research
Refereed limited

Conference

ICBBE '20

ICBBE '20: 2020 7th International Conference on Biomedical and Bioinformatics Engineering

November 6 - 9, 2020

Kyoto, Japan

Contributors

Other Metrics

View Article Metrics

Bibliometrics & Citations

Bibliometrics

Article Metrics

1
Total Citations
View Citations
27
Total Downloads

Downloads (Last 12 months)3
Downloads (Last 6 weeks)0

Reflects downloads up to 11 Feb 2025

Other Metrics

View Author Metrics

Citations

Cited By

Moroh JInnocent DChukwuocha UVasavada AKumar RSiddiq MRais MRabaan AAlshehri WAlharbi ABinateeq MHalwani MAl-Ahdal TPadhi BSah R(2023)Seasonal Variation and Geographical Distribution of COVID-19 across Nigeria (March 2020–July 2021)Vaccines10.3390/vaccines1102029811:2(298)Online publication date: 29-Jan-2023
https://doi.org/10.3390/vaccines11020298
Sharma SRani RKalra N(2023)Genomic Characterization of Emerging SARS-CoV-2: A Systematic ReviewCurrent Bioinformatics10.2174/157489361866623022811542318:5(375-408)Online publication date: Jun-2023
https://doi.org/10.2174/1574893618666230228115423

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Full Access

Get this Publication

View options

PDF

View or Download as a PDF file.

eReader

View online with eReader.

HTML Format

View this article in HTML Format.

Figures

Tables

Media

View Table of Conten